Fig. 1From: Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondentsOverview of the Fabry Disease Survey. ADA, antidrug antibodies; ERT, enzyme replacement therapy; FD, Fabry diseaseBack to article page